X

Health Care

Merck & Co. (MRK) stock research summary | Q3 2021

Merck is a multinational pharmaceutical company which announced its earnings call on October 28, 2021. Merck beat Zacks consensus on…

Biofrontera sees TAM of $4 Bln for lead product Ameluz: CEO Erica Monaco

Caption: iStock Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States.…

Avid Bioservices, Inc. (CDMO) Q2 2022 Earnings Call Transcript

Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim Brons -- Investor Relations, Vida Strategic…

HealthEquity, Inc. (HQY) Q3 2021 Earnings Call Transcript

HealthEquity, Inc. (NASDAQ: HQY) Q3 2021 earnings call dated Dec. 06, 2021 Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President/Chief Executive…

Eli Lilly and Company (LLY) Earnings: 3Q21 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported revenue of $6.7 billion for the third quarter of 2021, up 18% year-over-year.…

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed…

Biogen (BIIB) stock research summary | Q3 2021

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments…

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of…

Patterson Companies, Inc. (PDCO) Q2 2022 Earnings Call Transcript

Patterson Companies, Inc. (NASDAQ: PDCO) Q2 2022 earnings call dated Dec. 01, 2021 Corporate Participants: John M. Wright -- Vice President, Investor…

Biofrontera Inc (BFRI) Q3 2021 Earnings Call Transcript

Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck -- Head of Investor Relations…

BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results

Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to…

Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript

Centogene N.V.  (NASDAQ: CNTG) Q3 2021 earnings call dated Nov. 24, 2021 Corporate Participants: Lennart Streibel -- Investor Relations Andrin Oswald -- Chief Executive…

Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021

Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective…

Medtronic PLC (MDT) Q2 2022 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head -…

Colgate-Palmolive Company (CL) earnings Q3 2021 results

Colgate-Palmolive Company (NYSE: CL) reported its third-quarter financial results for the period ended September 30, 2021. GAAP net income for…

Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook

Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom…

Pfizer (PFE) stock research summary | Q3 2021

Pfizer delivered a solid performance in Q3 2021 with a triple-digit increase in revenue and profits growing many-fold. The company’s…

AbbVie (ABBV) stock research summary | Q3 2021

The AlphaStreet research report provides actionable data and insights into AbbVie’s fundamentals, the industry, and competition. The report is meant…

Aurora Cannabis Inc. (ACB) Q1 2022 Earnings Call Transcript

Aurora Cannabis Inc. (NYSE: ACB) Q1 2022 earnings call dated Nov. 09, 2021 Corporate Participants: Ananth Krishnan -- Vice President, Corporate Development…

IPO news: A few points to keep in mind as Vaxxinity makes its market debut this week

The healthcare industry continues to thrive and many companies in this sector have lined up to go public in recent…

Cara Therapeutics, Inc. (CARA) Q3 2021 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief…